Targeted autoimmune therapy medications are advanced treatments designed to specifically modulate the immune system in conditions like Rheumatoid Arthritis and Psoriasis. These therapies include biologics such as Adalimumab and Ustekinumab, which target specific immune pathways responsible for inflammation. By focusing on precise molecules or cells, they offer effective symptom control with reduced systemic side effects compared to traditional therapies. These medications are usually prescribed for moderate to severe cases and require medical supervision to monitor response, safety, and long-term disease management outcomes.